Toxicity and Safety Profiles of Methanolic Extract of Pistacia integerrima J. L. Stewart ex Brandis (PI) for Wistar Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The goals of this research were to evaluate acute (single-dose) and sub-acute (repeated-dose) toxicity profiles of methanolic extract of Pistacia integerrima J. L. Stewart ex Brandis (PI) for Wistar rats and to assess the safety profile of PI by observing physiological changes, mortality, changes in body weight, the histopathology of body organs, the hematology and the biochemistry of the animals. Methods: The toxicity profile of PI was evaluated using Wistar rats of both sexes. Animals were divided into four groups: Group 1; control group (normal saline), Group 2; PI-1 (250 mg/kg), Group 3; PI-2 (500 mg/kg), Group 4; PL-3 (1,000 mg/kg). An acute-toxicity study in which animals received a single dose of PI extract (2,000 mg/ kg) and were then observed for 14 days for changes in skin, fur, eye color, mucous membrane secretions and excretions, gait, posture, and tonic or clonic movements was performed according to guideline 425 of the Organization of Economic and Corporation Development (OECD). In the repeated-dose toxicity study (OECD – 407) animals received a daily dose of PI extract for 28 days (4 weeks). The parameters observed in this study include body weight, hematology and biochemistry of the animals. Results: In the acute toxicity study, no mortalities or changes in behavior were noted in the animals. The repeated-dose toxicity study was also devoid of any toxicity in the animals during the 28 days of testing with PI extract. The extract did not alter- the body weight, hematology or biochemistry of the animals. The methanolic extract of PI was to be found safe to the no-observed-adverse-effect-level (NOAEL) for the single- dose and repeated-dose toxicity tests in rats. Conclusion: The methanolic extract of PI was devoid of toxicity; hence, it can be used for various ayurvedic preparations and treatments of diseases.
Abstract
Objectives: The goals of this research were to evaluate acute (single-dose) and sub-acute (repeated-dose) toxicity profiles of methanolic extract of Pistacia integerrima J. L. Stewart ex Brandis (PI) for Wistar rats and to assess the safety profile of PI by observing physiological changes, mortality, changes in body weight, the histopathology of body organs, the hematology and the biochemistry of the animals. Methods: The toxicity profile of PI was evaluated using Wistar rats of both sexes. Animals were divided into four groups: Group 1; control group (normal saline), Group 2; PI-1 (250 mg/kg), Group 3; PI-2 (500 mg/kg), Group 4; PL-3 (1,000 mg/kg). An acute-toxicity study in which animals received a single dose of PI extract (2,000 mg/ kg) and were then observed for 14 days for changes in skin, fur, eye color, mucous membrane secretions and excretions, gait, posture, and tonic or clonic movements was performed according to guideline 425 of the Organization of Economic and Corporation Development (OECD). In the repeated-dose toxicity study (OECD – 407) animals received a daily dose of PI extract for 28 days (4 weeks). The parameters observed in this study include body weight, hematology and biochemistry of the animals. Results: In the acute toxicity study, no mortalities or changes in behavior were noted in the animals. The repeated-dose toxicity study was also devoid of any toxicity in the animals during the 28 days of testing with PI extract. The extract did not alter- the body weight, hematology or biochemistry of the animals. The methanolic extract of PI was to be found safe to the no-observed-adverse-effect-level (NOAEL) for the single- dose and repeated-dose toxicity tests in rats. Conclusion: The methanolic extract of PI was devoid of toxicity; hence, it can be used for various ayurvedic preparations and treatments of diseases.
참고문헌 (14)
- Balunas MJ, "Drug discovery from medicinal plants", Life Sci, 78(5), pp.431~441 (2005)
- Sharwan G, "Toxicity profile of traditional herbal medicine", J Ayu Herb Med, 1(3), pp.81~90 (2015)
- Anonymous, "The wealth of India", Raw material, 8, pp.120~122 (2005)
- Vashist H, "Pharmacognostical evaluation of P istacia integerrima stew ex brand", IJRAPR, 2(2), pp.70~77 (2012)
- Joshi UP, "In vitro antioxidant activity of galls of Pistacia integerrima", Pharmacologyonline, 2, pp.763~768 (2009)
- Khan MA, "Hepatoprotective effects of Berberis lycium, Galium aparine and Pistacia integerrima in carbon tetrachloride(ccl4)-treated rats", JPMI, 22(2), pp.91~94 (2008)
- Ramachandra YL, "In-vitro antimicrobial activity of Pistacia integerrima leaf gall extracts", Pharmacophore, 1(2), pp.149~154 (2010)
- Rahman SUr, "Evaluation of the stem bark of Pistacia integerrima stew ex Brandis for its antimicrobial and phytotoxic avtivities", Afr J Pharm Pharmacol, 5(8), pp.1170~1174 (2011)
- Adusumalli S, "Antiasthmatic activity of aqueous extract of Pistacia integerrima galls", Int J Pharm Pharm Sci, 5(2), pp.116~121 (2013)
- Uddin G, "Cytotoxic activity of extracts", fractions of various parts of Pistacia integerrima stewart, 2013, pp.3(2), 1~4
- Jindal A, "Physicochemical and phytochemical evaluation of Pistacia integerrima stew ex brand", Journal of Global Pharma Technology, 4(7), pp.24~27 (2012)
- Jain P, "SS. Acute and subacute toxicity studies of polyherbal formulation talisadya churna in experimental animal model", Mintage Journal of Pharmaceutical and Medical Sciences, 4(S1), pp.7~10 (2015)
- Jain P, "Acute and sub-acute toxicity studies of an ancient ayurvedic formulation: Agnimukhachurna", Columbia Journal of Pharmaceutical Sciences, (1), pp.18~22 (2014)
- Jain P, "Reproductive and developmental toxicity study of talisadya churna: an ancient polyherbal formulation", IAJPR, 6(5), pp.5641~5653 (2016)